Masoud Azodi

8.0k citations
162 papers · 3.3k indexed · 1 hit paper · h-index 32

Masoud Azodi

155 papers receiving 3.3k citations

Hit Papers

Niraparib monotherapy for late-line treatment of ovarian ...3772019202620212023100200300

Peers

Masoud Azodi
Comparison fields: 5 of 105
  • Reproductive Medicine 1.2k
  • Obstetrics and Gynecology 1.0k
  • Oncology 1.4k
  • Immunology 353
  • Cancer Research 249
Replace Stefania Cosio with:
Stefania Cosio Italy
Claes G. Tropé Norway
Kosei Hasegawa Japan
Margaret M. Steinhoff United States
Raji Ganesan United Kingdom
Tomoyasu Kato Japan
Ivo Meinhold‐Heerlein Germany
Robert Fruscio Italy
Debra A. Bell United States
Heidi J. Gray United States
Masoud Azodi relative to Stefania Cosio Italy Stefania Cosio's profile →
Citations per field
00.5×
Stefania Cosio · 1×
Citations per year

Countries citing papers authored by Masoud Azodi

Since Specialization
Citations

This map shows the geographic impact of Masoud Azodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masoud Azodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masoud Azodi more than expected).

Fields of papers citing papers by Masoud Azodi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masoud Azodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masoud Azodi. The network helps show where Masoud Azodi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Masoud Azodi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masoud Azodi Line = papers co-authored together Masoud Azodi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20235
4 20225
5 202114
6 20191
7 201820
8 201715
9 20172
10 20165
11 201630
12 201526
13 201526
14
EVALUATING THE NUTRITIONAL STATUS OF DORMITORY RESIDENT STUDENTS IN SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCE
20131
15 201246
16 201027
17 201040
18 201029
19 200521
20
Phenoxodiol phase Ib/II study in patients with recurrent ovarian cancer that are resistant to ≥ second line chemotherapy
200415

About Masoud Azodi

Masoud Azodi is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology, having authored 162 papers that have together received 3.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (44 papers), Uterine Myomas and Treatments (43 papers), Endometrial and Cervical Cancer Treatments (38 papers), HER2/EGFR in Cancer Research (20 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Sarcoma Diagnosis and Treatment (11 papers), Endometriosis Research and Treatment (11 papers) and Intraperitoneal and Appendiceal Malignancies (11 papers). The work is most often cited by research in Reproductive Medicine (1.2k citations), Obstetrics and Gynecology (1.0k citations) and Oncology (1.4k citations). Masoud Azodi has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Thomas Rutherford, Peter E. Schwartz, Alessandro D. Santin, Dan‐Arin Silasi, Elena Ratner, Stefania Bellone, Emiliano Cocco, Jessica N. McAlpine, Peter E. Schwartz and Natália Buza. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, Journal of Minimally Invasive Gynecology, Journal of Clinical Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026